Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
This document reports the completion of a Phase 2 trial evaluating BIND-014, a docetaxel nanoparticle formulation, in patients with metastat…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial [Phase 3]
A Phase 3 randomized trial evaluating implant and external radiation for prostate cancer with or without hormonal therapy has been terminate…
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Global Performance Evaluation of the AMS CONTINUUM™ Device [Phase 4]
Phase 4 global performance evaluation of the AMS CONTINUUM device for prostate cancer has been completed. The results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy [Phase 2]
Phase 2 trial assessing enzalutamide in prostate cancer patients who have never received hormone therapy has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Safety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific Antigen [Phase 2]
Phase 2 trial evaluating TAK-700 for safety and efficacy in nonmetastatic castration-resistant prostate cancer with rising PSA has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Safety Study of TAK-700 in Subjects With Prostate Cancer. [Phase 1, Phase 2]
A completed Phase 1/2 safety study of TAK-700 (orteronel) in prostate cancer patients is reported.
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology [Phase 2]
This Phase 2 trial evaluated MIP-1404 in men with high-risk prostate cancer scheduled for radical prostatectomy and extended pelvic lymph no…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer [Phase 2]
This document reports the completion results of an open Phase 2 trial evaluating the efficacy and safety of oral thalidomide in patients wit…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle [Phase 2]
Phase 2 trial evaluating rapid hormonal cycling as a treatment for prostate cancer has completed, and results have been posted. The study in…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer [Phase 1, Phase 2]
A clinical trial evaluating the combination of bevacizumab and erlotinib in hormone-refractory prostate cancer was terminated with results p…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: CT/MRI Co-registration Prostate Cancer
A CT/MRI co-registration trial for prostate cancer has completed (status: COMPLETED); no results are reported in the update.
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Testing the Helpfulness of 2 Decision Aids for Prostate Cancer [NA]
A clinical trial evaluating two decision aids for prostate cancer has completed. Results were posted on 2016-03-22.
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer [Phase 3]
A Phase 3 trial comparing chemotherapy with Strontium-89 versus chemotherapy alone in prostate cancer was terminated, with results posted in…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Efficacy and Safety Study of Xyotax to Treat Prostate Cancer [Phase 2]
This entry reports the completion of a Phase 2 trial evaluating Xyotax for prostate cancer, with results on efficacy and safety. The study w…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer [Phase 2]
Phase 2 trial comparing TroVax alone to TroVax plus GM-CSF in patients with prostate cancer, with the study completed.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Randomized Trial of Suicide Gene Therapy and Prostate Cancer [Phase 2]
Completed Phase 2 randomized trial of suicide gene therapy for prostate cancer; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer [Phase 2]
A Phase 2 trial evaluating Trovax in combination with docetaxel versus docetaxel alone in progressive hormone-refractory prostate cancer has…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer [Phase 2]
This Phase 2 trial evaluated GM-CSF, thalidomide, and docetaxel in prostate cancer and has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer [Phase 2]
A Phase 2 trial evaluating GM-CSF in combination with ketoconazole and mitoxantrone for progressive prostate cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy [Phase 2]
Phase 2 trial evaluating cetuximab alone or with docetaxel to treat prostate cancer before prostatectomy was terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating Abraxane (nab-paclitaxel) plus hormonal therapy as initial treatment for unresectable or metastatic prostate cancer…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Study of Immunotherapy to Treat Advanced Prostate Cancer [Phase 3]
Phase 3 immunotherapy trial for advanced prostate cancer completed; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy [NA]
A clinical trial update describing efforts to improve assessment and outcomes of permanent prostate implant therapy for prostate cancer, wit…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating ultrasound spectrum analysis to guide dose-escalated prostate brachytherapy planning in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer [Phase 2]
A Phase 2 study evaluating intraprostatic injection of 2-hydroxyflutamide (Liproca Depot) in men with localized prostate cancer has complete…